Micron to invest up to $3B in US chip supply chain, stock jumps on AI optimism

Micron Technology shares surged 6% in premarket trading on Thursday after the memory-chip maker announced plans to invest up to $3 billion to strengthen the US semiconductor supply chain. The bullish analyst commentary and improving sentiment toward AI-related memory demand further supported the stock. Micron announces $3 billion US supply chain investment Micron Technology said… Continue reading Micron to invest up to $3B in US chip supply chain, stock jumps on AI optimism

UK stocks decline as AstraZeneca tumbles after trial setback

The UK’s FTSE 100 declined on Thursday as investors assessed renewed tensions in the Middle East, while pharmaceutical heavyweight AstraZeneca weighed heavily on the benchmark after reporting disappointing results from a late-stage clinical trial. The blue-chip FTSE 100 index fell 0.6% to 10,417.63 points by 10:45 GMT. In contrast, the domestically focused FTSE 250 index… Continue reading UK stocks decline as AstraZeneca tumbles after trial setback

Nasdaq futures surge 190 points: 5 things to know before Wall Street opens

US futures steadied on Thursday, suggesting investors were not ready to abandon risk after another flare-up in the Gulf. Fresh US strikes on Iran and Tehran’s response had briefly pushed oil higher and revived inflation fears, but crude cooled from its highs before the open. That gave equities room to recover, even as traders stayed… Continue reading Nasdaq futures surge 190 points: 5 things to know before Wall Street opens

Column: Can AI’s biggest winners keep delivering blockbuster earnings?

We’ve just waved goodbye to the first half of 2026, and now investors are girding their loins for the second quarter earnings season. This begins next week when a large chunk of the giant US financial institutions report. This includes the world’s largest bank by market capitalisation, JP Morgan Chase, its biggest rival, Bank of… Continue reading Column: Can AI’s biggest winners keep delivering blockbuster earnings?

China raises EV ambitions with 30% fleet target by 2030

China has unveiled a new carbon-peaking action plan that targets new energy vehicles (NEVs) accounting for 30% of the country’s total vehicle fleet by 2030, marking a significant step in the electrification of the world’s largest automobile market. The State Council on Thursday released the “15th Five-Year Plan” Carbon Peaking Action Plan, outlining the country’s… Continue reading China raises EV ambitions with 30% fleet target by 2030

Magnificent 7 stocks are now at their cheapest in about 10 years

Magnificent 7 stocks that previously dominated equity markets are currently trading at their lowest valuation premiums in a decade. Following a challenging period where capital rapidly rotated toward hardware and semiconductor companies, the Magnificent 7 cohort presents an “increasingly attractive entry point” for targeted capital deployment. This stark valuation compression stems directly from rising debt… Continue reading Magnificent 7 stocks are now at their cheapest in about 10 years

Micron, AMD, Intel surge premarket: why chip stocks are roaring back

Chip stocks were set for a rebound on Thursday as investors stepped back into the AI hardware trade after two brutal sessions of profit-taking. Micron rose 3.5% in premarket trading to $982.05, while AMD and Intel also gained over 2.5% after recent Wall Street target hikes helped restore some confidence in the sector. The bounce… Continue reading Micron, AMD, Intel surge premarket: why chip stocks are roaring back

AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the primary objective in a late-stage clinical trial for a serious heart condition, dealing a setback to one of its most closely watched pipeline assets. The stock fell about 9.5% in London trading, making it the… Continue reading AstraZeneca shares plunge as Wainua fails late-stage heart disease trial

Why are Vistry, Taylor Wimpey, Barratt Redrow, Persimmon shares falling?

UK housebuilders are under intense pressure this year. Barratt Redrow shares have dropped by 27%, while Taylor Wimpey, Barratt Redrow, and Persimmon have plunged by 27%, 28%, and 25% this year. In contrast, the FTSE 100 Index has jumped by 3%.  Top UK housebuilding stocks | Source: TradingView The same trend is happening in the… Continue reading Why are Vistry, Taylor Wimpey, Barratt Redrow, Persimmon shares falling?